MULTIMODALITY TREATMENT OF LOCALLY ADVANCED PANCREATIC-CANCER

被引：9
作者：
WAGENER, DJT [1 ]
DEMULDER, PHM [1 ]
WILS, JA [1 ]
机构：
[1] LAURENTIUS HOSP,DEPT ONCOL,ROERMOND,NETHERLANDS
来源：
ANNALS OF ONCOLOGY | 1994年 / 5卷
关键词：
PANCREATIC CANCER; CHEMOTHERAPY; IRRADIATION; COMBINED MODALITY TREATMENT;
D O I：
10.1093/annonc/5.suppl_3.S81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The prognosis of locally advanced pancreatic cancer is poor (median survival 3-5 months). In view of the localized character of this disease several groups have explored the value of combined modality treatment. The conditions are that a good local treatment and an effective systemic treatment are available. Patients and methods: The results of irradiation and of chemotherapy in advanced disease are reviewed. Results: An overview of combined modality treatment has been given. Conclusions: Results of combined modality treatment are superior to irradiation alone or to symptomatic treatment.
引用
收藏
页码：S81 / S86
页数：6
相关论文
共 57 条
  • [1] IFOSFAMIDE AND MESNA - MARGINALLY ACTIVE IN PATIENTS WITH ADVANCED-CARCINOMA OF THE PANCREAS
    AJANI, JA
    ABBRUZZESE, JL
    GOUDEAU, P
    FAINTUCH, JS
    YEOMANS, AC
    BOMAN, BM
    NICAISE, C
    LEVIN, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (11) : 1703 - 1707
  • [2] ARBUCK SG, 1990, INT J PANCREATOL, V7, P209
  • [3] BERNARD S, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P84
  • [4] BILLINGSLEY JS, 1958, MAYO CLIN P STAFF M, V33, P426
  • [5] BRUHL P, 1979, INT J CLIN PHARM TH, V14, P29
  • [6] BUKOWSKI RM, 1983, CANCER, V52, P1577, DOI 10.1002/1097-0142(19831101)52:9<1577::AID-CNCR2820520906>3.0.CO
  • [7] 2-8
  • [8] SURVIVAL IN 1001 PATIENTS WITH CARCINOMA OF THE PANCREAS
    CONNOLLY, MM
    DAWSON, PJ
    MICHELASSI, F
    MOOSSA, AR
    LOWENSTEIN, F
    [J]. ANNALS OF SURGERY, 1987, 206 (03) : 366 - 373
  • [9] Cubilla A, 1978, PATHOL ANNU, V1, P241
  • [10] Cubilla AL, 1984, ATLAS TUMOR PATHOLOG
123456